RETRACTED: Activation of PPARγ mediates icaritin-induced cell cycle arrest and apoptosis in glioblastoma multiforme
- 1 April 2018
- journal article
- retracted article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 100, 358-366
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Rosiglitazone elevates sensitization of drug-resistant oral epidermoid carcinoma cells to vincristine by G2/M-phase arrest, independent of PPAR-γ pathwayBiomedicine & Pharmacotherapy, 2016
- Icaritin Sensitizes Human Glioblastoma Cells to TRAIL-Induced ApoptosisCell Biochemistry and Biophysics, 2015
- Anticancer effect of icaritin on human lung cancer cells through inducing s phase cell cycle arrest and apoptosisCurrent Medical Science, 2014
- Peptidoglycan induced expression of peroxisome proliferator-activated receptor γ in mouse peritoneal macrophages: Role of ERK and JNK MAP kinasesCytokine, 2012
- Modulating peroxisome proliferator–activated receptors for therapeutic benefit? Biology, clinical experience, and future prospectsAmerican Heart Journal, 2012
- An anticancer agent icaritin induces sustained activation of the extracellular signal-regulated kinase (ERK) pathway and inhibits growth of breast cancer cellsEuropean Journal of Pharmacology, 2011
- Biology of Glioma Cancer Stem CellsMolecules and Cells, 2009
- PPAR-γ ligand promotes the growth of APC-mutated HT-29 human colon cancer cells in vitro and in vivoInvestigational New Drugs, 2007
- Inhibition of gastric cancer cells associated angiogenesis by 15d-prostaglandin J2 through the downregulation of angiopoietin-1Cancer Letters, 2006
- Pioglitazone, a synthetic ligand for PPARγ, induces apoptosis in RB-deficient human colorectal cancer cellsApoptosis, 2006